Home / Fact sheets / Japan / Cervical quantitative data
Country fact sheet: Japan (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | |||
Population (not personally invited) | ||||||||||||||
Target population | 3059562 | 3175926 | 3599782 | 3984052 | 4715870 | 4685997 | 4022824 | 3788928 | 3972101 | 5093797 | 14528651 | 54 627 490 | ||
Annual target population | 1 529 781 | 1 587 963 | 1 799 891 | 1 992 026 | 2 357 935 | 2 342 998 | 2 011 412 | 1 894 464 | 1 986 050 | 2 546 898 | 0 | 0 | 7 264 325 | 27 313 743 |
Women screened | 142 277 | 240 234 | 397 540 | 415 996 | 509 817 | 444 676 | 383 513 | 326 665 | 375 894 | 459 017 | 0 | 0 | 598 498 | 4 294 127 |
Examination coverage rate (%) | 9.3 | 15.1 | 22.1 | 20.9 | 21.6 | 19.0 | 19.1 | 17.2 | 18.9 | 18.0 | 0.0 | 0.0 | 8.2 | 15.7 |
Result (All tests in the year) | ||||||||||||||
Positive | 6 516 | 10 403 | 13 579 | 12 408 | 13 665 | 10 822 | 7 122 | 3 792 | 2 891 | 3 211 | 0 | 0 | 4 097 | 88 506 |
Negative | 134 845 | 227 818 | 380 710 | 400 999 | 493 167 | 431 860 | 374 495 | 321 456 | 371 179 | 454 130 | 0 | 0 | 591 935 | 4 182 594 |
Unknown | 916 | 2 013 | 3 251 | 2 589 | 2 985 | 1 994 | 1 896 | 1 417 | 1 824 | 1 676 | 0 | 0 | 2 466 | 23 027 |
Referral for further assessment (%) | 4.6 | 4.3 | 3.4 | 3.0 | 2.7 | 2.4 | 1.9 | 1.2 | 0.8 | 0.7 | 0.0 | 0.0 | 0.7 | 2.1 |
Further assessment (all positive) | ||||||||||||||
Done | 4 069 | 7 037 | 9 618 | 9 185 | 10 053 | 8 141 | 5 326 | 2 922 | 2 246 | 2 535 | 0 | 0 | 3 124 | 64 256 |
Not done | 551 | 680 | 864 | 732 | 884 | 615 | 465 | 232 | 183 | 202 | 0 | 0 | 310 | 5 718 |
Unknown | 1 896 | 2 686 | 3 097 | 2 491 | 2 728 | 2 066 | 1 331 | 638 | 462 | 474 | 0 | 0 | 663 | 18 532 |
Further assessment participation rate (%) | 62.4 | 67.6 | 70.8 | 74.0 | 73.6 | 75.2 | 74.8 | 77.1 | 77.7 | 78.9 | 0.0 | 0.0 | 76.3 | 72.6 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Carcinoma | 16 | 45 | 116 | 178 | 202 | 164 | 118 | 136 | 94 | 120 | 0 | 0 | 157 | 1 346 |
CIN3 / Adenocarcinoma in situ (CGIN) | 104 | 444 | 922 | 913 | 994 | 556 | 274 | 136 | 139 | 141 | 0 | 0 | 147 | 4 770 |
CIN2 | 329 | 789 | 1 185 | 1 057 | 1 079 | 610 | 348 | 206 | 164 | 183 | 0 | 0 | 215 | 6 165 |
CIN1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 3 620 | 5 759 | 7 395 | 7 037 | 7 778 | 6 811 | 4 586 | 2 444 | 1 849 | 2 091 | 0 | 0 | 2 605 | 51 975 |